Immorna Biotherapeutics Receives US FDA IND Clearance to
Immorna Announces First Subject Dosed in a Phase 1 BioSpace
Immorna Announces First Subject Dosed in a Phase 1 Study of
Immorna Biotherapeutics Inc Receives IND Clearance to
Immorna Receives IND Clearance
to Conduct a Phase 1 Study of
Immorna Biotherapeutics Inc
